AU4058100A - Generic cdna or protein array for customized assays - Google Patents
Generic cdna or protein array for customized assaysInfo
- Publication number
- AU4058100A AU4058100A AU40581/00A AU4058100A AU4058100A AU 4058100 A AU4058100 A AU 4058100A AU 40581/00 A AU40581/00 A AU 40581/00A AU 4058100 A AU4058100 A AU 4058100A AU 4058100 A AU4058100 A AU 4058100A
- Authority
- AU
- Australia
- Prior art keywords
- cdna
- generic
- protein array
- customized
- assays
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12857899P | 1999-04-09 | 1999-04-09 | |
US60128578 | 1999-04-09 | ||
US53886200A | 2000-03-29 | 2000-03-29 | |
US09538862 | 2000-03-29 | ||
PCT/US2000/008611 WO2000061806A2 (en) | 1999-04-09 | 2000-03-31 | GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4058100A true AU4058100A (en) | 2000-11-14 |
Family
ID=26826721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40581/00A Abandoned AU4058100A (en) | 1999-04-09 | 2000-03-31 | Generic cdna or protein array for customized assays |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1183387A2 (en) |
AU (1) | AU4058100A (en) |
WO (1) | WO2000061806A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
GB0016836D0 (en) | 2000-07-07 | 2000-08-30 | Lee Helen | Improved dipstick assays (1) |
US9261460B2 (en) | 2002-03-12 | 2016-02-16 | Enzo Life Sciences, Inc. | Real-time nucleic acid detection processes and compositions |
US9777312B2 (en) | 2001-06-30 | 2017-10-03 | Enzo Life Sciences, Inc. | Dual polarity analysis of nucleic acids |
US20040161741A1 (en) | 2001-06-30 | 2004-08-19 | Elazar Rabani | Novel compositions and processes for analyte detection, quantification and amplification |
WO2003006657A2 (en) * | 2001-07-13 | 2003-01-23 | Custos Biotechnologie Gmbh | Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours |
EP1468116A2 (en) * | 2002-01-16 | 2004-10-20 | Dynal Biotech ASA | Method for isolating nucleic acids and protein from a single sample |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
KR100690948B1 (en) | 2004-06-17 | 2007-03-09 | 한국과학기술원 | Method for Cell Surface Display of Target Proteins Using FadL of E. coli |
KR100784261B1 (en) | 2006-01-02 | 2007-12-11 | 한국과학기술원 | Method for Cell Surface Displaying of Target Proteins Using Bacillus anthracis Exosporium |
DK3255146T3 (en) | 2009-03-16 | 2019-08-19 | Pangu Biopharma Ltd | Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities |
AU2010236913B2 (en) | 2009-03-31 | 2016-03-24 | Atyr Pharma, Inc. | Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities |
AU2011248625B2 (en) | 2010-04-26 | 2017-01-05 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
JP6294074B2 (en) | 2010-04-27 | 2018-03-14 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of isoleucyl-tRNA synthetase |
CA2797271C (en) | 2010-04-28 | 2021-05-25 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
CA2797393C (en) | 2010-04-29 | 2020-03-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
EP2563936B1 (en) | 2010-04-29 | 2018-03-14 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
CN103097523B (en) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds |
AU2011248227B2 (en) | 2010-05-03 | 2016-12-01 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
CN103096925A (en) | 2010-05-03 | 2013-05-08 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases |
ES2668207T3 (en) | 2010-05-03 | 2018-05-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic and antibody compositions related to fragments of methionyl-tRNA synthetases proteins |
CN102985103A (en) | 2010-05-04 | 2013-03-20 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
US8945541B2 (en) | 2010-05-14 | 2015-02-03 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases |
CA2799480C (en) | 2010-05-17 | 2020-12-15 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
EP2575856B1 (en) | 2010-05-27 | 2017-08-16 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
EP2575857B1 (en) | 2010-06-01 | 2018-01-24 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
WO2012021247A2 (en) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
CA2808539C (en) | 2010-08-25 | 2021-05-25 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
JP6039656B2 (en) | 2011-06-01 | 2016-12-07 | メディカル プログノシス インスティテュート エー/エス | Method and apparatus for predicting prognosis of cancer recurrence |
US8835387B2 (en) | 2012-02-16 | 2014-09-16 | Atyr Pharma, Inc. | Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases |
CA2892822C (en) | 2012-11-27 | 2023-08-08 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
US10392667B2 (en) | 2013-06-07 | 2019-08-27 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
WO2016008048A1 (en) | 2014-07-15 | 2016-01-21 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8920097D0 (en) * | 1989-09-06 | 1989-10-18 | Ici Plc | Amplification processes |
JPH06509946A (en) * | 1992-06-17 | 1994-11-10 | シティ・オブ・ホープ | How to detect and identify nucleic acids |
ATE244406T1 (en) * | 1993-05-10 | 2003-07-15 | Nissui Pharm Co Ltd | METHOD FOR DETERMINING MORE THAN ONE IMMUNOLOGICAL LIGAND AND DETERMINATION REAGENT AND SET THEREOF |
EP0920440B1 (en) * | 1996-02-09 | 2012-08-22 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US5804384A (en) * | 1996-12-06 | 1998-09-08 | Vysis, Inc. | Devices and methods for detecting multiple analytes in samples |
AU8267998A (en) * | 1997-06-24 | 1999-01-04 | Trustees Of Boston University | High density streptavidin supports |
DE19741716A1 (en) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Recognition system |
US6232066B1 (en) * | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
GB9902970D0 (en) * | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Novel matrix |
WO2000058516A2 (en) * | 1999-03-26 | 2000-10-05 | Whitehead Institute For Biomedical Research | Universal arrays |
-
2000
- 2000-03-31 EP EP00919976A patent/EP1183387A2/en not_active Withdrawn
- 2000-03-31 WO PCT/US2000/008611 patent/WO2000061806A2/en not_active Application Discontinuation
- 2000-03-31 AU AU40581/00A patent/AU4058100A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000061806A3 (en) | 2001-12-20 |
EP1183387A2 (en) | 2002-03-06 |
WO2000061806A2 (en) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4058100A (en) | Generic cdna or protein array for customized assays | |
AU5173400A (en) | Protein kinases | |
AU4488200A (en) | Modified protein matrices | |
AU6906800A (en) | Membrane associated proteins | |
AU1701001A (en) | Antibodies against signal regulator proteins | |
AU1290001A (en) | Antibodies | |
AU2434199A (en) | Protein | |
AU3440900A (en) | Assay system | |
AU4935000A (en) | Antibodies | |
AU2925600A (en) | Genetic screening | |
AU6123899A (en) | Supports for immobilizing dna or the like | |
AU6045900A (en) | Interaction-activated proteins | |
AU3902099A (en) | Tethered function assay for protein function | |
AU3162500A (en) | Homogeneous fluorescence assay | |
AU2190801A (en) | Binding protein | |
AU4188500A (en) | Protein c derivatives | |
AU2452301A (en) | Protein methylarginine-specific antibodies | |
AU4352000A (en) | Clasp-2 transmembrane proteins | |
AU1531801A (en) | Novel assay | |
AU1751801A (en) | Protein c derivatives | |
AU7537400A (en) | Assay | |
AU1881200A (en) | Novel proteins | |
AU4245500A (en) | Protein transport assays | |
AU2538899A (en) | Protein kinase c | |
AU6983000A (en) | Chimeric proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |